CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51 | -5.6% | 36,500 | 0.0% | 0.00% | – |
Q2 2023 | $54 | -11.5% | 36,500 | 0.0% | 0.00% | – |
Q1 2023 | $61 | +19.6% | 36,500 | 0.0% | 0.00% | – |
Q4 2022 | $51 | -99.9% | 36,500 | 0.0% | 0.00% | – |
Q3 2022 | $57,000 | -28.8% | 36,500 | 0.0% | 0.00% | – |
Q2 2022 | $80,000 | +50.9% | 36,500 | +69.9% | 0.00% | – |
Q1 2022 | $53,000 | -57.3% | 21,480 | +3.9% | 0.00% | – |
Q4 2021 | $124,000 | -98.7% | 20,680 | -96.1% | 0.00% | -100.0% |
Q4 2020 | $9,528,000 | +21.3% | 529,627 | -4.3% | 0.00% | 0.0% |
Q3 2020 | $7,852,000 | – | 553,359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
Atom Investors LP | 33,798 | $84,000 | 0.04% |
XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
Walleye Capital LLC | 123,305 | $306,000 | 0.01% |